COVID-19 Impact on Global Acquired Hemophilia Treatment Market Size, Status and Forecast 2020-2026

September 2020 | 97 pages | ID: C8C7EA9E0EFBEN
QYResearch

Abstracts

This report focuses on the global Acquired Hemophilia Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Acquired Hemophilia Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Baxalta, Inc.
• Baxter Healthcare Corporation
• Bristol-Myers Squibb
• Genentech, Inc.
• Novo Nordisk A/S
• Ferring B.V.
• Sanofi SA

Market segment by Type, the product can be split into

• Traditional Therapy
• Advanced Therapy

Market segment by Application, split into

• Hospitals
• Clinic
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Acquired Hemophilia Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Acquired Hemophilia Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Acquired Hemophilia Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Acquired Hemophilia Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Acquired Hemophilia Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Traditional Therapy
  1.4.3 Advanced Therapy
1.5 Market by Application
  1.5.1 Global Acquired Hemophilia Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals
  1.5.3 Clinic
  1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Acquired Hemophilia Treatment Industry Impact
  1.6.1 How the Covid-19 is Affecting the Acquired Hemophilia Treatment Industry
    1.6.1.1 Acquired Hemophilia Treatment Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Acquired Hemophilia Treatment Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Acquired Hemophilia Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Acquired Hemophilia Treatment Market Perspective (2015-2026)
2.2 Acquired Hemophilia Treatment Growth Trends by Regions
  2.2.1 Acquired Hemophilia Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Acquired Hemophilia Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Acquired Hemophilia Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Acquired Hemophilia Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Acquired Hemophilia Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Acquired Hemophilia Treatment Players by Market Size
  3.1.1 Global Top Acquired Hemophilia Treatment Players by Revenue (2015-2020)
  3.1.2 Global Acquired Hemophilia Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Acquired Hemophilia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Acquired Hemophilia Treatment Market Concentration Ratio
  3.2.1 Global Acquired Hemophilia Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Acquired Hemophilia Treatment Revenue in 2019
3.3 Acquired Hemophilia Treatment Key Players Head office and Area Served
3.4 Key Players Acquired Hemophilia Treatment Product Solution and Service
3.5 Date of Enter into Acquired Hemophilia Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Acquired Hemophilia Treatment Historic Market Size by Type (2015-2020)
4.2 Global Acquired Hemophilia Treatment Forecasted Market Size by Type (2021-2026)

5 ACQUIRED HEMOPHILIA TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Acquired Hemophilia Treatment Market Size by Application (2015-2020)
5.2 Global Acquired Hemophilia Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Acquired Hemophilia Treatment Market Size (2015-2020)
6.2 Acquired Hemophilia Treatment Key Players in North America (2019-2020)
6.3 North America Acquired Hemophilia Treatment Market Size by Type (2015-2020)
6.4 North America Acquired Hemophilia Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Acquired Hemophilia Treatment Market Size (2015-2020)
7.2 Acquired Hemophilia Treatment Key Players in Europe (2019-2020)
7.3 Europe Acquired Hemophilia Treatment Market Size by Type (2015-2020)
7.4 Europe Acquired Hemophilia Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China Acquired Hemophilia Treatment Market Size (2015-2020)
8.2 Acquired Hemophilia Treatment Key Players in China (2019-2020)
8.3 China Acquired Hemophilia Treatment Market Size by Type (2015-2020)
8.4 China Acquired Hemophilia Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Acquired Hemophilia Treatment Market Size (2015-2020)
9.2 Acquired Hemophilia Treatment Key Players in Japan (2019-2020)
9.3 Japan Acquired Hemophilia Treatment Market Size by Type (2015-2020)
9.4 Japan Acquired Hemophilia Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Acquired Hemophilia Treatment Market Size (2015-2020)
10.2 Acquired Hemophilia Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Acquired Hemophilia Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Acquired Hemophilia Treatment Market Size by Application (2015-2020)

11 INDIA

11.1 India Acquired Hemophilia Treatment Market Size (2015-2020)
11.2 Acquired Hemophilia Treatment Key Players in India (2019-2020)
11.3 India Acquired Hemophilia Treatment Market Size by Type (2015-2020)
11.4 India Acquired Hemophilia Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Acquired Hemophilia Treatment Market Size (2015-2020)
12.2 Acquired Hemophilia Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Acquired Hemophilia Treatment Market Size by Type (2015-2020)
12.4 Central & South America Acquired Hemophilia Treatment Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Baxalta, Inc.
  13.1.1 Baxalta, Inc. Company Details
  13.1.2 Baxalta, Inc. Business Overview and Its Total Revenue
  13.1.3 Baxalta, Inc. Acquired Hemophilia Treatment Introduction
  13.1.4 Baxalta, Inc. Revenue in Acquired Hemophilia Treatment Business (2015-2020))
  13.1.5 Baxalta, Inc. Recent Development
13.2 Baxter Healthcare Corporation
  13.2.1 Baxter Healthcare Corporation Company Details
  13.2.2 Baxter Healthcare Corporation Business Overview and Its Total Revenue
  13.2.3 Baxter Healthcare Corporation Acquired Hemophilia Treatment Introduction
  13.2.4 Baxter Healthcare Corporation Revenue in Acquired Hemophilia Treatment Business (2015-2020)
  13.2.5 Baxter Healthcare Corporation Recent Development
13.3 Bristol-Myers Squibb
  13.3.1 Bristol-Myers Squibb Company Details
  13.3.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
  13.3.3 Bristol-Myers Squibb Acquired Hemophilia Treatment Introduction
  13.3.4 Bristol-Myers Squibb Revenue in Acquired Hemophilia Treatment Business (2015-2020)
  13.3.5 Bristol-Myers Squibb Recent Development
13.4 Genentech, Inc.
  13.4.1 Genentech, Inc. Company Details
  13.4.2 Genentech, Inc. Business Overview and Its Total Revenue
  13.4.3 Genentech, Inc. Acquired Hemophilia Treatment Introduction
  13.4.4 Genentech, Inc. Revenue in Acquired Hemophilia Treatment Business (2015-2020)
  13.4.5 Genentech, Inc. Recent Development
13.5 Novo Nordisk A/S
  13.5.1 Novo Nordisk A/S Company Details
  13.5.2 Novo Nordisk A/S Business Overview and Its Total Revenue
  13.5.3 Novo Nordisk A/S Acquired Hemophilia Treatment Introduction
  13.5.4 Novo Nordisk A/S Revenue in Acquired Hemophilia Treatment Business (2015-2020)
  13.5.5 Novo Nordisk A/S Recent Development
13.6 Ferring B.V.
  13.6.1 Ferring B.V. Company Details
  13.6.2 Ferring B.V. Business Overview and Its Total Revenue
  13.6.3 Ferring B.V. Acquired Hemophilia Treatment Introduction
  13.6.4 Ferring B.V. Revenue in Acquired Hemophilia Treatment Business (2015-2020)
  13.6.5 Ferring B.V. Recent Development
13.7 Sanofi SA
  13.7.1 Sanofi SA Company Details
  13.7.2 Sanofi SA Business Overview and Its Total Revenue
  13.7.3 Sanofi SA Acquired Hemophilia Treatment Introduction
  13.7.4 Sanofi SA Revenue in Acquired Hemophilia Treatment Business (2015-2020)
  13.7.5 Sanofi SA Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Acquired Hemophilia Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Acquired Hemophilia Treatment Revenue
Table 3. Ranking of Global Top Acquired Hemophilia Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Acquired Hemophilia Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Traditional Therapy
Table 6. Key Players of Advanced Therapy
Table 7. COVID-19 Impact Global Market: (Four Acquired Hemophilia Treatment Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Acquired Hemophilia Treatment Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Acquired Hemophilia Treatment Players to Combat Covid-19 Impact
Table 12. Global Acquired Hemophilia Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Acquired Hemophilia Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Acquired Hemophilia Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Acquired Hemophilia Treatment Market Share by Regions (2015-2020)
Table 16. Global Acquired Hemophilia Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Acquired Hemophilia Treatment Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Acquired Hemophilia Treatment Market Growth Strategy
Table 22. Main Points Interviewed from Key Acquired Hemophilia Treatment Players
Table 23. Global Acquired Hemophilia Treatment Revenue by Players (2015-2020) (Million US$)
Table 24. Global Acquired Hemophilia Treatment Market Share by Players (2015-2020)
Table 25. Global Top Acquired Hemophilia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acquired Hemophilia Treatment as of 2019)
Table 26. Global Acquired Hemophilia Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Acquired Hemophilia Treatment Product Solution and Service
Table 29. Date of Enter into Acquired Hemophilia Treatment Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Acquired Hemophilia Treatment Market Size by Type (2015-2020) (Million US$)
Table 32. Global Acquired Hemophilia Treatment Market Size Share by Type (2015-2020)
Table 33. Global Acquired Hemophilia Treatment Revenue Market Share by Type (2021-2026)
Table 34. Global Acquired Hemophilia Treatment Market Size Share by Application (2015-2020)
Table 35. Global Acquired Hemophilia Treatment Market Size by Application (2015-2020) (Million US$)
Table 36. Global Acquired Hemophilia Treatment Market Size Share by Application (2021-2026)
Table 37. North America Key Players Acquired Hemophilia Treatment Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Acquired Hemophilia Treatment Market Share (2019-2020)
Table 39. North America Acquired Hemophilia Treatment Market Size by Type (2015-2020) (Million US$)
Table 40. North America Acquired Hemophilia Treatment Market Share by Type (2015-2020)
Table 41. North America Acquired Hemophilia Treatment Market Size by Application (2015-2020) (Million US$)
Table 42. North America Acquired Hemophilia Treatment Market Share by Application (2015-2020)
Table 43. Europe Key Players Acquired Hemophilia Treatment Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Acquired Hemophilia Treatment Market Share (2019-2020)
Table 45. Europe Acquired Hemophilia Treatment Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Acquired Hemophilia Treatment Market Share by Type (2015-2020)
Table 47. Europe Acquired Hemophilia Treatment Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Acquired Hemophilia Treatment Market Share by Application (2015-2020)
Table 49. China Key Players Acquired Hemophilia Treatment Revenue (2019-2020) (Million US$)
Table 50. China Key Players Acquired Hemophilia Treatment Market Share (2019-2020)
Table 51. China Acquired Hemophilia Treatment Market Size by Type (2015-2020) (Million US$)
Table 52. China Acquired Hemophilia Treatment Market Share by Type (2015-2020)
Table 53. China Acquired Hemophilia Treatment Market Size by Application (2015-2020) (Million US$)
Table 54. China Acquired Hemophilia Treatment Market Share by Application (2015-2020)
Table 55. Japan Key Players Acquired Hemophilia Treatment Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Acquired Hemophilia Treatment Market Share (2019-2020)
Table 57. Japan Acquired Hemophilia Treatment Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Acquired Hemophilia Treatment Market Share by Type (2015-2020)
Table 59. Japan Acquired Hemophilia Treatment Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Acquired Hemophilia Treatment Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Acquired Hemophilia Treatment Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Acquired Hemophilia Treatment Market Share (2019-2020)
Table 63. Southeast Asia Acquired Hemophilia Treatment Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Acquired Hemophilia Treatment Market Share by Type (2015-2020)
Table 65. Southeast Asia Acquired Hemophilia Treatment Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Acquired Hemophilia Treatment Market Share by Application (2015-2020)
Table 67. India Key Players Acquired Hemophilia Treatment Revenue (2019-2020) (Million US$)
Table 68. India Key Players Acquired Hemophilia Treatment Market Share (2019-2020)
Table 69. India Acquired Hemophilia Treatment Market Size by Type (2015-2020) (Million US$)
Table 70. India Acquired Hemophilia Treatment Market Share by Type (2015-2020)
Table 71. India Acquired Hemophilia Treatment Market Size by Application (2015-2020) (Million US$)
Table 72. India Acquired Hemophilia Treatment Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Acquired Hemophilia Treatment Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Acquired Hemophilia Treatment Market Share (2019-2020)
Table 75. Central & South America Acquired Hemophilia Treatment Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Acquired Hemophilia Treatment Market Share by Type (2015-2020)
Table 77. Central & South America Acquired Hemophilia Treatment Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Acquired Hemophilia Treatment Market Share by Application (2015-2020)
Table 79. Baxalta, Inc. Company Details
Table 80. Baxalta, Inc. Business Overview
Table 81. Baxalta, Inc. Product
Table 82. Baxalta, Inc. Revenue in Acquired Hemophilia Treatment Business (2015-2020) (Million US$)
Table 83. Baxalta, Inc. Recent Development
Table 84. Baxter Healthcare Corporation Company Details
Table 85. Baxter Healthcare Corporation Business Overview
Table 86. Baxter Healthcare Corporation Product
Table 87. Baxter Healthcare Corporation Revenue in Acquired Hemophilia Treatment Business (2015-2020) (Million US$)
Table 88. Baxter Healthcare Corporation Recent Development
Table 89. Bristol-Myers Squibb Company Details
Table 90. Bristol-Myers Squibb Business Overview
Table 91. Bristol-Myers Squibb Product
Table 92. Bristol-Myers Squibb Revenue in Acquired Hemophilia Treatment Business (2015-2020) (Million US$)
Table 93. Bristol-Myers Squibb Recent Development
Table 94. Genentech, Inc. Company Details
Table 95. Genentech, Inc. Business Overview
Table 96. Genentech, Inc. Product
Table 97. Genentech, Inc. Revenue in Acquired Hemophilia Treatment Business (2015-2020) (Million US$)
Table 98. Genentech, Inc. Recent Development
Table 99. Novo Nordisk A/S Company Details
Table 100. Novo Nordisk A/S Business Overview
Table 101. Novo Nordisk A/S Product
Table 102. Novo Nordisk A/S Revenue in Acquired Hemophilia Treatment Business (2015-2020) (Million US$)
Table 103. Novo Nordisk A/S Recent Development
Table 104. Ferring B.V. Company Details
Table 105. Ferring B.V. Business Overview
Table 106. Ferring B.V. Product
Table 107. Ferring B.V. Revenue in Acquired Hemophilia Treatment Business (2015-2020) (Million US$)
Table 108. Ferring B.V. Recent Development
Table 109. Sanofi SA Company Details
Table 110. Sanofi SA Business Overview
Table 111. Sanofi SA Product
Table 112. Sanofi SA Revenue in Acquired Hemophilia Treatment Business (2015-2020) (Million US$)
Table 113. Sanofi SA Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Acquired Hemophilia Treatment Market Share by Type: 2020 VS 2026
Figure 2. Traditional Therapy Features
Figure 3. Advanced Therapy Features
Figure 4. Global Acquired Hemophilia Treatment Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Clinic Case Studies
Figure 7. Others Case Studies
Figure 8. Acquired Hemophilia Treatment Report Years Considered
Figure 9. Global Acquired Hemophilia Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Acquired Hemophilia Treatment Market Share by Regions: 2020 VS 2026
Figure 11. Global Acquired Hemophilia Treatment Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Acquired Hemophilia Treatment Market Share by Players in 2019
Figure 14. Global Top Acquired Hemophilia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acquired Hemophilia Treatment as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Acquired Hemophilia Treatment Revenue in 2019
Figure 16. North America Acquired Hemophilia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Acquired Hemophilia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Acquired Hemophilia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Acquired Hemophilia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Acquired Hemophilia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Acquired Hemophilia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Acquired Hemophilia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Baxalta, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Baxalta, Inc. Revenue Growth Rate in Acquired Hemophilia Treatment Business (2015-2020)
Figure 25. Baxter Healthcare Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Baxter Healthcare Corporation Revenue Growth Rate in Acquired Hemophilia Treatment Business (2015-2020)
Figure 27. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Bristol-Myers Squibb Revenue Growth Rate in Acquired Hemophilia Treatment Business (2015-2020)
Figure 29. Genentech, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Genentech, Inc. Revenue Growth Rate in Acquired Hemophilia Treatment Business (2015-2020)
Figure 31. Novo Nordisk A/S Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Novo Nordisk A/S Revenue Growth Rate in Acquired Hemophilia Treatment Business (2015-2020)
Figure 33. Ferring B.V. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Ferring B.V. Revenue Growth Rate in Acquired Hemophilia Treatment Business (2015-2020)
Figure 35. Sanofi SA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Sanofi SA Revenue Growth Rate in Acquired Hemophilia Treatment Business (2015-2020)
Figure 37. Bottom-up and Top-down Approaches for This Report
Figure 38. Data Triangulation
Figure 39. Key Executives Interviewed